Product: Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA  19454.
Reason for recall: Failed Dissolution Specifications: low out of specification dissolution results found during stability testing.
Recall initiated: 20170217
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated